0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders

Buy Now

Breakthrough Business Models - Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (Paperback, New) Loot Price: R1,306
Discovery Miles 13 060
Breakthrough Business Models - Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary...

Breakthrough Business Models - Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (Paperback, New)

Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Robert Giffin, Sally Robinson, Theresa Wizemann

 (sign in to rate)
Loot Price R1,306 Discovery Miles 13 060 | Repayment Terms: R122 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns. On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases. Table of Contents Front Matter 1 Introduction and Overview 2 Current Model for Financing Drug Development: From Concept Through Approval 3 The Food and Drug Administration's Orphan Drug Program 4 Diverse Funding Models 5 Strategies for Facilitating Sharing of Research Materials and Data 6 Strategies for Navigating Intellectual Property 7 Strategies for Facilitating Clinical Trials 8 Summary References Appendix A: Agenda Appendix B: Speaker Biographies Appendix C: Resources

General

Imprint: National Academies Press
Country of origin: United States
Release date: March 2009
First published: 2008
Authors: Institute of Medicine • Board on Health Sciences Policy • Forum on Drug Discovery, Development, and Translation • Robert Giffin • Sally Robinson • Theresa Wizemann
Dimensions: 229 x 152 x 10mm (L x W x T)
Format: Paperback
Pages: 150
Edition: New
ISBN-13: 978-0-309-12088-3
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > General
LSN: 0-309-12088-8
Barcode: 9780309120883

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners